DAK Gesundheit
9
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
11%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)
Role: collaborator
Post-COVID-19 Monitoring in Routine Health Insurance Data
Role: collaborator
Incidence of Diabetes After a COVID-19 Infection
Role: collaborator
Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation
Role: collaborator
Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)
Role: collaborator
Children of Mentally Ill Parents-Network - CHIMPS-NET
Role: collaborator
Children Affected by Rare Disease and Their Families Network
Role: collaborator
Evaluation of a Cross-sectional Coordinated, Severity Stepped, Evidence-based Care Model for Mental Disorders
Role: collaborator
Medical In-Patient Rehabilitation in Rheumatoid Arthritis
Role: collaborator
All 9 trials loaded